Control group:Conventional western medicine treatment + placebo

3 trials

Sponsors

Guanganmen Hospital, Chinese Academy of Chinese Medical Sciences, Southwest Medical University Affiliated Hospital of Traditional Chinese Medicine Longmatan District Luzhou City Sichuan Province

Conditions

Unstable angina pectorischronic heart failure

Phase 2

A Randomized Controlled Trial for Gualou Danshen Granules in the Treatment of Unstable Angina Pectoris Patients with Phlegm-Blood Stasis Syndrome

Active, not recruitingITMCTR2000003201

Guanganmen Hospital, Chinese Academy of Chinese Medical SciencesUnstable angina pectoris

Start: 2020-06-01Updated: 2023-02-20

A Randomized Controlled Trial for Gualou Danshen Granules in the Treatment of Unstable Angina Pectoris Patients with Phlegm-Blood Stasis Syndrome

Active, not recruitingChiCTR2000031780

Guanganmen Hospital, Chinese Academy of Chinese Medical SciencesUnstable angina pectoris

Start: 2020-06-01Updated: 2020-04-13

Unknown Phase

A multicenter randomized double-blind placebo-controlled study on the application of plasma proteome to analyze the therapeutic mechanism and drug sensitivity prediction of ShenYu Yangxin Capsule in the treatment of chronic heart failure

RecruitingITMCTR2025001287

Southwest Medical University Affiliated Hospital of Traditional Chinese Medicine Longmatan District Luzhou City Sichuan Provincechronic heart failure

Start: 2025-01-01Updated: 2025-07-21

Related Papers

A randomized controlled trial for gualou danshen granules in the treatment of unstable angina pectoris patients with phlegm-blood stasis syndrome

Medicine2020-08-136 citations